Moteur de recherche d’entreprises européennes
Financement de l’UE (5 783 800 €) : Réutilisation du moulage par injection pour les fournitures médicales grâce à la fabrication additive Hor 27/11/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Réutilisation du moulage par injection pour les fournitures médicales grâce à la fabrication additive
The modern world is fast-evolving, interconnected and highly mobile, thus posing a significant challenge in harmonizing risk mitigation measures against emerging biological hazards. For many years the risk of emerging infectious diseases with pandemic potential was declared a major threat to global health security and addressed by many stakeholders around the world. The delay in imposing risk mitigation measures is crucial and can make the difference between a local outbreak with few cases to a pandemic with countless sick and deceased citizens, as severely demonstrated by the recent outbreak of Coronavirus disease 2019 (COVID-19). It is of paramount importance that appropriate and proportionate measures to each phase of the pandemic (e.g. from situations with no reported cases, sporadic, local clusters of cases, to widespread sustained transmission) are immediately implemented to interrupt human-to-human transmission chains, prevent further spread and reduce the intensity of COVID-19 outbreak. Immediate activation of national emergency response mechanisms and pandemic preparedness plans to ensure containment and mitigation of COVID-19 with non-pharmaceutical public health measures is critical for delaying transmission or decreasing the peak of the outbreak, in order to allow healthcare systems to prepare and cope with an increased influx of patients. However, shortages and other gaps in the global medical supply chain represent a mismatch of supply and demand when supply is low and/or demand is high for particular items. With healthcare workers and other first responders feeling the impact of supply chains disrupted by unprecedented challenges, many large and small businesses from outside the traditional healthcare procurement system are reconfiguring to mass produce critical medical consumables. In order to address supply shortages, particularly in medical supplies and protective equipment, some countries have employed less traditional instruments.
| ANG Alberto Nicolini Group Srl | 90 300 € |
| Biog3D Monoprosopi ΙΚΕ | 387 625 € |
| Conify ΙΚΕ | 350 000 € |
| Elvez, Proizvodnja Kabelske Konfekcije IN Predelava Plasticnih MAS d.o.o. | 299 950 € |
| Ethnicon Metsovion Polytechnion | 658 625 € |
| Ethniko Kai Kapodistriako Panepistimio Athinon | 118 750 € |
| Gruppo RPM Srl | 0,00 € |
| IES R&D | 0,00 € |
| Innovation in Research & Engineering Solutions | 297 500 € |
| Institut de Recherche Technologique Jules Verne | 400 000 € |
| Instituto Tecnologico de Aragon | 368 125 € |
| Integrated Environmental Solutions Ltd. | 148 750 € |
| Iungo S.p.A. | 149 625 € |
| New Infrared Technologies SL | 201 250 € |
| Norges Teknisk-Naturvitenskapelige Universitet Ntnu | 431 263 € |
| Pascoe Engineering Ltd. | 400 750 € |
| Producta Srl | 201 250 € |
| Sidam Srl | 319 900 € |
| Stil Gomma Srl | 320 775 € |
| Tinexta Innovation Hub S.p.A. | 280 613 € |
| University of Strathclyde | 358 750 € |
https://cordis.europa.eu/project/id/101016262
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.